Device Trial Radar · NCT05209828
Post-market Clinical Follow-up of Pfmmedical Ports
Last checked: Nov 20, 2026Latest source record: Apr 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
149
Actual
Start
Apr 13, 2022
Primary completion
Mar 9, 2023
Study completion Mar 9, 2023
Sponsor
- Lead sponsor
- pfm medical gmbhNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, monocentric, non-randomised, observational post-market clinical follow-up study in Germany to obtain post-market information on the pfmmedical ports with a follow-up (FU) of 6 months. The focus is on patient reported satisfaction, clinical application, and complication rates.
Conditions
- Vascular Access Port
- Patient Satisfaction
Interventions
pfmmedical implantable vascular access portsDevice
Implantion of an implantable vascular access port which facilitates repeated vascular access intended for the delivery of medications, intravenous fluids, parenteral nutrition solutions or blood products and blood sampling using a Huber needle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patients satisfactionTime frame: 6 months after port implantation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Heidelberg University Hospital
Heidelberg, Baden-Wurttemberg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.